Home | Links | Contact Us | Press | Post a job | Bookmark
Search jobs:
Home Biotechnology and Pharmaceutical Senior-Medical-Director-Hematology-Oncology

 Senior Level Medical Device Engineer
**Our client is an exceptionally well-funded start-up company with a strong leadership team -- a ...


 Open Access NMR Support
AccountAbilities is seeking experience Associate to support a Major Pharmaceutical Company to ...


 Statistician (Manager/Associate Director)
Description: - Participate as a team member on cross-functional full development nonclinical drug ...


 Associate Director - Import/Export Logistics
Our Client - Fortune 250 pharmaceutical Co. needs senior level manager in their Procurement Group ...


 Biostatistician
DESCRIPTIONBiostatistician III needed in Stamford, Connecticut Compensation is commensurate with ...


 Team Administrator
PAREXEL International Corporation is one of the largest bio/pharmaceutical outsourcing companies in ...


 QUALITY CONTROL TECHNICIAN - Bio Tech
Stamford, CT USA   We are a Bio Tech company located in Southern Fairfield County, C...


 CLINICAL PROJECT COORDINATOR
Clinical Project Coordinator needed in Stamford, Connecticut. 6 MONTH CONTRACT Compensation is ...


 Project Manager
  Join Our Dynamic Team and Accelerate Your Career ArisGlobal is a dynamic and growing ...


 Sr. QA Specialist (Change Control & Documentation)
Job Summary Description: The Sr. QA Specialist (QACC&D) is responsible for the development, control,...


 Senior Medical Director, Hematology-Oncology

Details
Country: USA
Location: CT Cheshire
Total applied: 40

Relevant Work Experience: 7+ to 10 Years
Career Level: Manager (Manager/Supervisor of Staff)
Education Level: Doctorate
Job Type: Employee
Job Status: Full Time

Senior Medical Director, Hematology-Oncology

Overall Description
This person will be the internal and external medical champion of all hematology/oncology products at Alexion. This person will lead discussions with and influence academic opinion leaders, prescribers, and colleagues at the FDA. This person will be responsible for leadership and medical monitoring of one or more Phase II - IV clinical drug trials. He or she will assist in protocol development, study conduct, and data interpretation, and will interact with study sites (principal investigators), vendors (e.g. central laboratories, CRO?s), and other departments within Alexion.

Position Responsibilities

Drug Development Planning
Assist in planning the overall strategy (clinical and otherwise) for products in clinical development. Assist in IND and NDA filing activities for drug candidates. Interact with FDA (by teleconference or attendance at meetings). Assist in due diligence of potential in-licensing drug candidates. Interact with academic experts and advisory panel members at international symposia.

Trial Start-up
Assist in protocol development, including protocol outline, protocol, and protocol amendments. This will require interaction with Medical Directors, Clinical Project Leaders, Safety Officers, Statistics, Regulatory, Project Management, Clinical Supply, and Marketing personnel. Participate in investigators? meetings as well as internal and external educational seminars related to study protocol. Oversee recruitment of participating investigators and the compilation and distribution of study start-up packages. Identify and interact with outside experts and opinion leaders.

Trial Conduct
Serve as the primary medical contact with collaborators and opinion leaders. Serve as medical expert with internal and external (CRO, independent contractors) staff regarding protocol related issues. Assist in developing and monitoring adherence to program timelines (e.g. enrollment, data cleaning, and statistical output timelines). Oversee investigator recruitment efforts and resolve recruitment problems in conjunction with the Clinical Project Leader. Track and compile patient screening and enrollment information. Perform data listings review, and assist in study report generation as needed.

Budget Responsibilities
Assist in preparing site-specific study budgets. Assist in preparing departmental budgets and short and long term budget projections for ongoing projects.

Safety Review
Periodically review all study related patient safety data. Interact with Safety Officer and Regulatory Affairs regarding reporting of serious adverse events to FDA. Visit selected sites, with or without a field monitor to trouble-shoot, train/retrain staff, if needed.

Trial Reporting
Assist in creating and reviewing all study related documents, including justification documents, CRF?s, study tables and listings, statistical analysis plans, and final study reports. Prepare pertinent safety and/or efficacy summaries for official documents.

Post-Marketing Activities
This person will be the internal and external medical champion of all hematology/oncology products at Alexion. This person will lead discussions with and influence academic opinion leaders, prescribers, and colleagues at the FDA. This person will interact with internal Pharmacovigilance group in the review of post-marketing safety-related occurrences.

 

Educational Requirements
MD degree and board eligibility in internal medicine, oncology, hematology or hematology-oncology.

Work Experience


A proven record of direct experience working with clinical trials as investigator, subinvestigator or medical monitor is desirable. A working knowledge of general medicine and drug therapy including pharmacology, toxicology, trial methodology and clinical pharmacology and an in depth knowledge and understanding of scientific principles for controlled trials is essential. Knowledge of regulatory requirements for NDA submission is beneficial. Professionalism is essential, as is willingness to work in a team and travel.

 

Alexion Pharmaceuticals is a publicly traded company engaged in the development of novel drugs for the treatment of hematologic disorders, autoimmune diseases, cardiovascular disorders and cancer.

Alexion offers a highly competitive package of base and incentive compensation, group healthcare coverage, tuition reimbursement, relocation assistance, a 401(K) plan and stock options.

Alexion is an Equal Opportunity/Affirmative Action Employer.

- Apply for Senior Medical Director, Hematology-Oncology

Your email:
Friend email:

Related jobs
  Sales Representative
Our client is the largest privately-held biopharmaceutical company in the United States dedicated to the research and discovery of novel drugs and therapeutics for ...
  Manufacturing Associate Team Leader
Manufacturing Associate Team Leader   Our client an award winning, aggressively growing Greater New Haven based Biotech seeks a Manufacturing Associate Team L...
  Scientific Analyst II
Genaissance Pharmaceuticals, a Clinical Data company, is a world leader in the discovery and use of human gene variation for the development of a new ...
  Bioinformatics Scientist II/III
Bioinformatics Scientist II/III   454 Life Sciences is commercializing novel instrumentation and services for rapidly and comprehensively conducting high-...
  PK Research Scientist
An Extraordinary Opportunity to Contribute to the Research and Development of Innovative Therapies! Kelly Scientific Resources is assisting a major Research Institute ...
  CLINICAL DATA SPECIALIST
Job Responsibilities: Determine and direct the program level strategy for data related activities for global drug development programs. Programs may be in one or more ...
  LIQUID HANDLING – TECHNICAL SPECIALIST
PLEASE VISIT OUR WEBSITE AT...
  SAS PROGRAMMERS
Top 10 Pharmaceutical Company with a location in Wallingford, CT is seeking 2 SAS Programmers to join their team. Requirements: MS or BS in computing or a scientific ...
  PRINCIPAL VETERINARY PATHOLOGIST
Job Responsibilities: Discovery Working Group representation. Develop early safety assessment, ensure appropriate toxicology studies and liability screens are performed ...
  ASSOCIATE DIRECTOR - SIGNAL TRANSDUCTION
Job Responsibilities: Responsible for directing the following activities for assigned clinical drug studies. Directs the design, development and execution of clinical ...

Related press releases
Poverty rates on the decline - but 22% of Britons still live below the line
Poverty in Britain has fallen to levels last seen in the late 1980s, according to a survey published by the Joseph Rowntree Foundation today. The New Policy Institute f...
We like consistently good rates
Recent research from Intelligent Finance, the internet arm of the Halifax, claims that consistently high rates on savings accounts are a scarce commodity. Headline-gra...
Rate freeze wins warm welcome from all sides
The Bank of England left interest rates on hold yesterday, to a chorus of approval from the City, industry and the retail sector. The monetary policy committee had been...
Growth in services points to rate rises next year
Service sector firms, the main engine of the economy, expanded at their fastest pace for more than six years in November, the latest snapshot of the sector showed yesterd...
Business confidence survives rate rise
Last month's interest rate rise has not hurt business confidence and optimism, according to two new surveys published today. One report shows the service sector at its mo...
Nigel Melville rates the teams and who will win each battle
Josh Lewsey 8 v Mat Rogers 8 Rogers still bears the marks of their last meeting - an unsightly rib, damaged by Lewsey's tackle in Melbourne. Both are going well but h...
Lloyds TSB ups current account rate
Lloyds TSB today launched the latest attack in the battle for current account customers by announcing it would pay up to 4.5% interest on account balances. But the offe...
Debt fears put rate rises on hold
Christmas shoppers may be spared a rise in borrowing costs after the Bank of England said yesterday that it plans to proceed cautiously with further interest rate increas...
OFT tells Barclays its 0% rate is not 100%
Barclays faced more embarrassment over its Barclaycard credit card yesterday after the Office of Fair Trading forced it to withdraw adverts for its "0% forever" offer. ...
Class divide' in languages as dropout rates rise
Allowing schoolchildren to drop languages at age 14 is reinforcing an existing class divide, warns a report from national education bodies. Schools with more pupils on fr...
0.004

Archive: All jobs - Links - Job Search Engines - Medical Encyclopedia

Copyright (c)2006 Eofhr.org/jobs - All rights reserved